1. The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine
   Tyler C. Beck et al, 2020, Frontiers in Pharmacology CrossRef
2. The Implications of Zinc Therapy in Combating the COVID-19 Global Pandemic
   Nandeeta Samad et al, 2021, Journal of Inflammation Research CrossRef
3. Artemisinins—a Promising New Treatment for Systemic Lupus Erythematosus: a Descriptive Review
   Xiaozhen Mu et al, 2018, Current Rheumatology Reports CrossRef
4. Whole blood hydroxychloroquine: Does genetic polymorphism of cytochrome P450 enzymes have a role?
   Njundu Jatta et al, 2023, Clinical and Experimental Medicine CrossRef
5. Bibliometric and visual analysis of cardiovascular diseases and COVID-19 research
   Namin Wei et al, 2022, Frontiers in Public Health CrossRef
6. The Therapeutic Effect of Artemisinin and Its Derivatives in Kidney Disease
   Ming Xia et al, 2020, Frontiers in Pharmacology CrossRef
7. Therapeutic potential of artemisinin and its derivatives in managing kidney diseases
   Qi Jin et al, 2023, Frontiers in Pharmacology CrossRef
8. HEALING PROTOCOLS AND TOXICOLOGY TESTS FOR SEQUELAE OF COVID‑19 INJECTABLES
   Ki-Yeob Jeon, 2024, International Journal of Research -GRANTHAALAYAH CrossRef